Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Summary
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
52.4(c) 53.73(c) 54.68(c) 53.04(c) 54.27(c) Last
72 660 758 64 598 388 59 849 358 46 361 744 37 077 736 Volume
-2.96% +2.54% +1.77% -3.00% +2.32% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 81 517 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 14,0x
Yield 2021 2,91%
Sales 2022 84 067 M - -
Net income 2022 22 492 M - -
Net Debt 2022 18 117 M - -
P/E ratio 2022 13,5x
Yield 2022 3,10%
Capitalization 305 B 305 B -
EV / Sales 2021 4,08x
EV / Sales 2022 3,84x
Nbr of Employees 78 500
Free-Float 59,3%
More Financials
Company
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines... 
Sector
Pharmaceuticals
Calendar
02/01Earnings Release
More about the company
Ratings of Pfizer, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about PFIZER, INC.
03:40pU.S. administers 470.3 mln doses of COVID-19 vaccines -CDC
RE
07:06aHow Can Scientists Update Coronavirus Vaccines for Omicron? a Microbiologist Answers 5 ..
AQ
12/04U.S. administers 468.5 mln doses of COVID-19 vaccines- CDC
RE
12/04Chile reports first case of omicron variant of coronavirus
AQ
12/04Federal Contractor And Subcontractor Vaccine Mandate Temporarily Enjoined In Kentucky, ..
AQ
12/03FDA adds strict safety warnings on arthritis drugs from Pfizer, AbbVie and Lilly
RE
12/03Health Care Ticks Lower As Pfizer Gains - Health Care Roundup
DJ
12/03PFIZER : FDA Issues Update to XELJANZ« Prescribing Information in the United States
PU
12/03U.S. administers 466.3 mln doses of COVID-19 vaccines - CDC
RE
12/03Merck to supply up to 1 mln courses of COVID-19 pill to Canada
RE
12/03Canada Signs Deal for 1 Mln Doses of Pfizer Covid Antiviral and 500K Merck's Covid Pill
MT
12/03Vaccine makers could make Omicron-specific booster, says Fauci
RE
12/03BioNTech Capable of Quickly Modifying Vaccine for Omicron Variant, CEO Says
MT
12/03BioNTech CEO Expects To Modify COVID-19 Vaccine To Omicron Variant
MT
12/03Malaysia Confirms First Case of New COVID-19 Variant
MT
More news
News in other languages on PFIZER, INC.
01:53pCORONAVIRUS : le point sur la pandémie dans le monde
10:37aPremiers signaux "encourageants" sur la gravité des cas d'Omicron (Fauci)
12/04COVID : la vaccination des enfants au menu du Conseil de défense lundi
12/04COVID-19 : pourquoi Omicron ne remet pas en cause l'intérêt d'un rappel vaccinal
12/03VALNEVA : subit un revers sur le marché de la dose de rappel
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Stock Trading Strategies
PFIZER, INC. - 11/03
No turn-around in sight
BUY
More Stock Trading Analysis
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 54,27 $
Average target price 49,58 $
Spread / Average Target -8,65%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.47.43%304 610
JOHNSON & JOHNSON1.27%419 583
ROCHE HOLDING AG17.62%341 364
NOVO NORDISK A/S64.51%244 010
ELI LILLY AND COMPANY47.55%222 641
ABBVIE INC.8.18%210 113